Down-regulation of the chemokine (c-c motif) receptor 9 (Ccr9) contributes to the atherosclerosis-lowering activity of the angiotensin-converting enzyme inhibitor captopril

Authors
Publication date
1 September 2016
Publisher
Elsevier BV
Doi

    Abstract

    Abstract is not available.

      Similar works

      Full text

      thumbnail-image

      Available Versions

      Crossref

      redirect
      oaiinfo:doi/10.1016%2Fj.atheroscl...
      Last time updated on 10/01/2021